...
首页> 外文期刊>The Lancet >Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: An observational first-in-human trial
【24h】

Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: An observational first-in-human trial

机译:工程化的自体软骨组织用于肿瘤切除后的鼻重建:一项观察性的首次人类试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background Autologous native cartilage from the nasal septum, ear, or rib is the standard material for surgical reconstruction of the nasal alar lobule after two-layer excision of non-melanoma skin cancer. We assessed whether engineered autologous cartilage grafts allow safe and functional alar lobule restoration. Methods In a fi rst-in-human trial, we recruited fi ve patients at the University Hospital Basel (Basel, Switzerland). To be eligible, patients had to be aged at least 18 years and have a two-layer defect (≥50% size of alar subunit) after excision of non-melanoma skin cancer on the alar lobule. Chondrocytes (isolated from a 6 mm cartilage biopsy sample from the nasal septum harvested under local anaesthesia during collection of tumour biopsy sample) were expanded, seeded, and cultured with autologous serum onto collagen type I and type III membranes in the course of 4 weeks. The resulting engineered cartilage grafts (25 mm × 25 mm × 2 mm) were shaped intra-operatively and implanted after tumour excision under paramedian forehead or nasolabial fl aps, as in standard reconstruction with native cartilage. During fl ap refi nement after 6 months, we took biopsy samples of repair tissues and histologically analysed them. The primary outcomes were safety and feasibility of the procedure, assessed 12 months after reconstruction. At least 1 year after implantation, when reconstruction is typically stabilised, we assessed patient satisfaction and functional outcomes (alar cutaneous sensibility, structural stability, and respiratory fl ow rate). Findings Between Dec 13, 2010, and Feb 6, 2012, we enrolled two women and three men aged 76-88 years. All engineered grafts contained a mixed hyaline and fi brous cartilage matrix. 6 months after implantation, reconstructed tissues displayed fi bromuscular fatty structures typical of the alar lobule. After 1 year, all patients were satisfi ed with the aesthetic and functional outcomes and no adverse events had been recorded. Cutaneous sensibility and structural stability of the reconstructed area were clinically satisfactory, with adequate respiratory function. Interpretation Autologous nasal cartilage tissues can be engineered and clinically used for functional restoration of alar lobules. Engineered cartilage should now be assessed for other challenging facial reconstructions. Funding Foundation of the Department of Surgery, University Hospital Basel; and Krebsliga beider Basel.
机译:背景技术鼻中隔,耳朵或肋骨的自体天然软骨是非黑素瘤皮肤癌两层切除后鼻翼小叶手术重建的标准材料。我们评估了工程化的自体软骨移植物是否允许安全和功能性的前小叶小叶修复。方法在一项首次人体试验中,我们在巴塞尔大学医院(瑞士巴塞尔)招募了五名患者。为了符合条件,患者必须至少年满18岁,并且在翼状小叶切除非黑色素瘤皮肤癌后出现两层缺损(≥阿拉尔亚基大小的50%)。软骨细胞(从收集肿瘤活检样品期间在局部麻醉下收集的鼻中隔的6毫米软骨活检样品中分离)扩增,接种并在4周内用自体血清培养到I型和III型胶原膜上。手术中对所得的工程软骨移植物(25 mm×25 mm×2 mm)进行成形,并在肿瘤切除后将其植入前额中位或鼻唇瓣,与天然软骨的标准重建一样。在6个月后的瓣膜翻修期间,我们对修复组织进行了活检,并对其进行了组织学分析。重建后12个月评估的主要结果是手术的安全性和可行性。植入后至少一年,当重建通常稳定时,我们评估了患者的满意度和功能结局(皮肤敏感性,结构稳定性和呼吸流速)。研究结果从2010年12月13日到2012年2月6日,我们招募了两名年龄在76-88岁的女性和三名男性。所有工程移植物均含有混合的透明质酸和纤维软骨基质。植入后6个月,重建的组织显示出典型的翼状小叶纤维肌脂肪结构。一年后,所有患者的美学和功能结果均令人满意,未记录到不良事件。重建区域的皮肤敏感性和结构稳定性在临床上令人满意,并具有足够的呼吸功能。解释自体鼻软骨组织可被工程化并临床用于翼状小叶的功能性恢复。现在应该对工程软骨进行其他具有挑战性的面部重建进行评估。巴塞尔大学医院外科系经费基金会;和Krebsliga beider巴塞尔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号